Virus budding and the ESCRT pathway J Votteler, WI Sundquist Cell host & microbe 14 (3), 232-241, 2013 | 600 | 2013 |
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ... Cell host & microbe 6 (5), 409-421, 2009 | 513 | 2009 |
A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells C Banning, J Votteler, D Hoffmann, H Koppensteiner, M Warmer, ... PloS one 5 (2), e9344, 2010 | 189 | 2010 |
Designed proteins induce the formation of nanocage-containing extracellular vesicles J Votteler, C Ogohara, S Yi, Y Hsia, U Nattermann, DM Belnap, NP King, ... Nature 540 (7632), 292-295, 2016 | 134 | 2016 |
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin A Kühl, C Banning, A Marzi, J Votteler, I Steffen, S Bertram, I Glowacka, ... The Journal of infectious diseases 204 (suppl_3), S850-S860, 2011 | 89 | 2011 |
Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. A Karlas, M Irgang, J Votteler, V Specke, M Ozel, R Kurth, J Denner Robert Koch-Institut, 2010 | 63 | 2010 |
Attenuated protein expression vectors for use in siRNA rescue experiments E Morita, J Arii, D Christensen, J Votteler, WI Sundquist Biotechniques, 1, 2012 | 53 | 2012 |
Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317 S Bolduan, J Votteler, V Lodermeyer, T Greiner, H Koppensteiner, ... Virology 416 (1-2), 75-85, 2011 | 48 | 2011 |
Binding of substrates to the central pore of the Vps4 ATPase is autoinhibited by the microtubule interacting and trafficking (MIT) domain and activated by MIT interacting … H Han, N Monroe, J Votteler, B Shakya, WI Sundquist, CP Hill Journal of Biological Chemistry 290 (21), 13490-13499, 2015 | 43 | 2015 |
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly J Votteler, L Neumann, S Hahn, F Hahn, P Rauch, K Schmidt, ... Retrovirology 8, 1-16, 2011 | 33 | 2011 |
Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release J Votteler, E Iavnilovitch, O Fingrut, V Shemesh, D Taglicht, O Erez, ... BMC biochemistry 10, 1-14, 2009 | 33 | 2009 |
The evolution of pandemic and non-pandemic HIV-1 strains has been driven by Tetherin antagonism D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ... Cell host & microbe 6 (5), 409, 2009 | 21 | 2009 |
Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the … J Votteler, N Studtrucker, S Sörgel, J Münch, E Rücker, F Kirchhoff, ... Journal of virology 81 (17), 9572-9576, 2007 | 21 | 2007 |
Human immunodeficiency viruses: molecular biology J Votteler, U Schubert Academic Press, 2008 | 19 | 2008 |
Perinuclear localization of the HIV-1 regulatory protein Vpr is important for induction of G2-arrest S Sörgel, K Fraedrich, J Votteler, M Thomas, T Stamminger, U Schubert Virology 432 (2), 444-451, 2012 | 17 | 2012 |
Polypeptide assemblies and methods for the production thereof N King, W Sundquist, J Votteler, H Yang, D Baker, B Jacob, M Lajoie, ... US Patent 10,501,733, 2019 | 11 | 2019 |
Role of cyclophilin A in HIV replication J Votteler, V Wray, U Schubert Future Medicine Ltd 2 (1), 65-78, 2007 | 11 | 2007 |
Mutation of the highly conserved Ser-40 of the HIV-1 p6 gag protein to Phe causes the formation of a hydrophobic patch, enhances membrane association, and polyubiquitination of Gag F Hahn, C Setz, M Friedrich, P Rauch, SM Solbak, NÅ Frøystein, ... Viruses 6 (10), 3738-3765, 2014 | 9 | 2014 |
Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein A Sharma, K Bruns, R Röder, P Henklein, J Votteler, V Wray, U Schubert BMC Structural Biology 9, 1-14, 2009 | 8 | 2009 |
Ubiquitin ligases as therapeutic targets in HIV-1 infection J Votteler, U Schubert Expert Opinion on Therapeutic Targets 12 (2), 131-143, 2008 | 8 | 2008 |